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Macrophages are sentinel cells essential for tissue homeostasis and host defence. 
Owing to their plasticity, macrophages acquire a range of functional phenotypes in 
response to microenvironmental stimuli. Of those, M(IFN-γ) and M(IL-4/IL-13) 
macrophage activation states are well known for their opposing pro- and anti-
inflammatory roles. Imbalance in these populations of macrophages has been implicated 
in progression of various diseases. Macrophages also comprise the first line of an 
organism’s defence against Mycobacterium tuberculosis, the causative agent of 
tuberculosis; interactions between the bacteria and host macrophages define the infection 
outcome. 
The area of mammalian transcriptional regulation progressed remarkably with 
recent advances in high-throughput technologies. Enhancers emerged as crucial 
regulatory DNA elements capable of activating transcription of target genes at distance in 
an orientation-independent manner. A recent discovery revealed that enhancers can be 
transcribed themselves into enhancer RNAs, or eRNAs. Enhancers were shown to be 
pervasive, yet the associated regulatory patterns remain largely unknown and require 
further research. 
In this thesis, we investigated in silico transcribed enhancers in mouse tissues and 
cell lines, with a particular focus on macrophages. We have performed a large-scale study 
to identify transcribed enhancers across multiple tissues and to characterise their 
ii 
 
properties. In macrophages, we have established the most accurate, to our knowledge, 
genome-wide catalogue of transcribed enhancers and enhancer-gene regulatory 
interactions. We have inferred enhancers that might drive transcriptional responses of 
protein-coding genes upon M(IFN-γ) and M(IL-4/IL-13) macrophage activation, and 
demonstrated stimuli specificity of regulatory associations. We have conducted the first 
to our knowledge study of the role of transcribed enhancers in macrophage response to 
Mycobacterium tuberculosis infection. Taken together, the present work provides new 
insights into genome-wide enhancer-mediated transcriptional control of macrophage 
protein-coding genes in different conditions. Given the increasing promise for enhancer- 
and chromatin-directed therapy, this work paves the way for further studies towards host-
directed therapies and novel treatments for tuberculosis and immune diseases associated 
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Table of abbreviations 
Abbreviation Meaning 
BMDM Bone marrow-derived macrophages 
bp Base pair 
CAGE Cap analysis of gene expression 
ChIP-seq Chromatin immunoprecipitation followed by sequencing 
DEG Differentially expressed gene 
DNA Deoxyribonucleic acid 
eRNA Enhancer RNA 
E-P Enhancer-promoter 
FDR False discovery rate 
GRO-seq  Global nuclear run-on sequencing 
GSEA Gene set enrichment analysis 
H3K27ac Acetylation of histone H3 at lysine 27  
H3K4me1 Monomethylation of histone H3 at lysine 4 




lncRNA Long-noncoding RNA 




M.tb Mycobacterium tuberculosis  
Mb Megabase 
mRNA Messenger RNA 
PRR Pattern recognition receptor 
RNA Ribonucleic acid 
RNAPII RNA polymerase II  
RNA-seq RNA sequencing (whole transcriptome shotgun sequencing) 
SE Super (stretch) enhancer 
SEM Standard error of the mean 
TAD Topologically associating domain 
TB Tuberculosis  
TF Transcription factor 
TFBS Transcription factor binding site 
TLR Toll-like receptor 
TPM Tags per million 
TSS  Transcription start site 
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